CliffBio
small molecule

8-MOP

METHOXSALEN

Loss of exclusivity—loss of exclusivity
CompanyVALEANT PHARMACEUTICALS INTERNATIONAL

Drug detail

Brand name8-MOP
Active ingredientMETHOXSALEN
Strength10MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
Marketing statusDISCN

More from VALEANT PHARMACEUTICALS INTERNATIONAL

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

8-MOP patent cliff — loss of exclusivity — | CliffBio